Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Rapid engraftment of mast cells of donor origin in a case of acute myeloid leukemia with mast cell leukemia after allogeneic stem cell transplantation

Summary:

Mastocytosis is a rare disease characterized by an abnormal increase of mast cells in tissues. We report a case of acute myeloid leukemia (AML) with t(8;21) and mast cell leukemia (MCL) in which the mastocytosis persisted after standard chemotherapy and allogeneic stem cell transplantation, although the myeloid leukemia achieved molecular complete remission soon after induction chemotherapy. Donor-type mast cells were noted on d31 after transplant. No c-kit mutation was found before or after the transplant. This represents the first reported case in which rapid engraftment of mast cells of donor origin was documented. Thus, the possibility that the mast cell originates from a common myeloid precursor cell may be questioned and a reactive process should be considered in some cases of systemic mastocytosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Valent P, Horny HP, Escribano L et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001; 25: 603–625.

    Article  CAS  Google Scholar 

  2. Kirshenbaum AS, Kessler SW, Goff JP et al. Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol 1991; 146: 1410–1415.

    CAS  PubMed  Google Scholar 

  3. Furitsu T, Tsujimura T, Tono T et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993; 92: 1736–1744.

    Article  CAS  Google Scholar 

  4. Longley BJ, Tyrrell L, Lu S et al. Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 1996; 12: 312–314.

    Article  CAS  Google Scholar 

  5. Nagata H, Worobec AS, Oh CK et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995; 92: 10560–10564.

    Article  CAS  Google Scholar 

  6. Kitayama H, Kanakura Y, Furitsu T et al. Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 1995; 85: 790–798.

    CAS  PubMed  Google Scholar 

  7. van Dongen HM, Macintyre EA, Gabert JA et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Leukemia 1999; 13: 1901–1928.

    Article  CAS  Google Scholar 

  8. Fritsche-Polanz R, Jordan JH, Feix A et al. Mutation analysis of c-kit in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis. Br J Haematol 2001; 113: 357–364.

    Article  CAS  Google Scholar 

  9. Fodinger M, Fritsch G, Winkler K et al. Origin of human mast cells: development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation. Blood 1994; 84: 2954–2959.

    CAS  PubMed  Google Scholar 

  10. Valent P, Spanblochl E, Sperr W et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor /kit ligand in long term culture. Blood 1992; 80: 2237–2245.

    CAS  PubMed  Google Scholar 

  11. Rottem M, Okada T, Goff JP et al. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate form a CD34+/Fc epsilon RI-cell population. Blood 1994; 84: 2489–2496.

    CAS  PubMed  Google Scholar 

  12. Galli SJ, Kitamura Y . Animal model of human disease. Genetically mast-cell-deficient W/Wv and Sl/Sld mice. Am J Pathol 1987; 127: 191–198.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Steingrimsson E, Moore KJ, Lamoreux ML et al. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat Genet 1994; 8: 256–263.

    Article  CAS  Google Scholar 

  14. Ebi Y, Kanakura Y, Jippo-Kanemoto T et al. Low c-kit expression of cultured mast cells of mi/mi genotype may be involved in their defective responses to fibroblasts that express the ligand for c-kit. Blood 1992; 80: 1454–1462.

    CAS  PubMed  Google Scholar 

  15. Ronnov-Jessen D, Lovgreen Nielsen P, Horn T . Persistence of systemic mastocytosis after allogeneic bone marrow transplantation in spite of complete remission of the associated myelodysplastic syndrome. Bone Marrow Transplant 1991; 8: 413–415.

    CAS  PubMed  Google Scholar 

  16. Przepiorka D, Giralt S, Khouri I et al. Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: review of forty cases. Am J Hematol 1998; 57: 24–28.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank to Dr P Valent, Department of Internal Medicine I, University of Vienna, Austria for valuable assistance.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, TY., Chen, JS., Huang, WT. et al. Rapid engraftment of mast cells of donor origin in a case of acute myeloid leukemia with mast cell leukemia after allogeneic stem cell transplantation. Bone Marrow Transplant 32, 111–114 (2003). https://doi.org/10.1038/sj.bmt.1704098

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704098

Keywords

Search

Quick links